Cronos Group Stock Performance

CRON Stock  USD 1.79  0.04  2.19%   
The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cronos' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cronos is expected to be smaller as well. At this point, Cronos Group has a negative expected return of -0.21%. Please make sure to confirm Cronos' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Cronos Group performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cronos Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
JavaScript chart by amCharts 3.21.1512345678910111213142025FebMar -505
JavaScript chart by amCharts 3.21.15Cronos Group Cronos Group Dividend Benchmark Dow Jones Industrial
1
Disposition of 3220 shares by Jeffrey Jacobson of Cronos at 2.84 subject to Rule 16b-3
02/18/2025
2
How Is Cronos Group Navigating Market Changes and Growth Strategies
02/24/2025
3
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings A Full Recap
02/27/2025
4
Q4 2024 Cronos Group Inc Earnings Call Transcript
02/28/2025
5
Acquisition by Arye Weigensberg of 21482 shares of Cronos subject to Rule 16b-3
03/07/2025
6
Cronos Group Inc. to Speak at the 37th Annual Roth Conference - StockTitan
03/10/2025
7
Disposition of 25378 shares by Shannon Buggy of Cronos subject to Rule 16b-3
03/11/2025
8
Acquisition by Gorenstein Michael Ryan of 1019736 shares of Cronos subject to Rule 16b-3
03/12/2025
9
SBI Securities Co. Ltd. Makes New 30,000 Investment in Cronos Group Inc. - Defense World
03/13/2025
10
Disposition of 5940 shares by Shannon Buggy of Cronos at 1.89 subject to Rule 16b-3
03/14/2025
11
Acquisition by James Holm of 96724 shares of Cronos subject to Rule 16b-3
03/18/2025
12
Disposition of 3000000 shares by Gorenstein Michael Ryan of Cronos subject to Rule 16b-3
03/21/2025
13
Acquisition by Mcginness James Andrew Iii of 12689 shares of Cronos subject to Rule 16b-3
03/25/2025
14
Is Cronos Group Inc. the Best Cannabis Stock to Buy According to Billionaires
03/28/2025
Begin Period Cash Flow669.3 M
  

Cronos Relative Risk vs. Return Landscape

If you would invest  206.00  in Cronos Group on January 1, 2025 and sell it today you would lose (27.00) from holding Cronos Group or give up 13.11% of portfolio value over 90 days. Cronos Group is currently does not generate positive expected returns and assumes 2.3956% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Cronos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketCRON 0.00.51.01.52.02.5 -0.20-0.15-0.10-0.050.00
       Risk  
Given the investment horizon of 90 days Cronos is expected to under-perform the market. In addition to that, the company is 2.7 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.01 per unit of volatility.

Cronos Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cronos' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cronos Group, and traders can use it to determine the average amount a Cronos' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0861

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCRON

Estimated Market Risk

 2.4
  actual daily
21
79% of assets are more volatile

Expected Return

 -0.21
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cronos is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cronos by adding Cronos to a well-diversified portfolio.

Cronos Fundamentals Growth

Cronos Stock prices reflect investors' perceptions of the future prospects and financial health of Cronos, and Cronos fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cronos Stock performance.
Return On Equity0.0363
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-300%-250%-200%-150%-100%-50%
Return On Asset-0.0294
Profit Margin0.35 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%2,500%3,000%
Operating Margin(0.45) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-250%-200%-150%-100%-50%
Current Valuation(172.41 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%5,000%10,000%15,000%20,000%25,000%
Shares Outstanding382.53 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%
Price To Earning36.41 X
Price To Book0.64 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%50%
Price To Sales5.89 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-800%-600%-400%-200%
Revenue117.61 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-60,000%-50,000%-40,000%-30,000%-20,000%-10,000%0%
Gross Profit30.48 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10,000%-5,000%0%5,000%10,000%
EBITDA(50.21 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%200,000%
Net Income40.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400,000%-300,000%-200,000%-100,000%0%
Cash And Equivalents944.89 M
Cash Per Share2.50 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100,000%200,000%300,000%400,000%500,000%600,000%700,000%
Total Debt2.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%
Debt To Equity0.01 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%800%1,000%
Current Ratio26.18 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%
Book Value Per Share2.78 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%7,000%
Cash Flow From Operations18.84 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50,000%100,000%
Earnings Per Share0.11 X
Market Capitalization692.38 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%
Total Asset1.17 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%
Retained Earnings457.71 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150,000%-100,000%-50,000%0%
Working Capital886.41 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset15.37 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000,000%2,000,000%3,000,000%4,000,000%
Current Liabilities10.59 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%

About Cronos Performance

By examining Cronos' fundamental ratios, stakeholders can obtain critical insights into Cronos' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cronos is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 130.92  137.47 
Return On Tangible Assets 0.04  0.04 
Return On Capital Employed(0.07)(0.07)
Return On Assets 0.04  0.04 
Return On Equity 0.04  0.04 

Things to note about Cronos Group performance evaluation

Checking the ongoing alerts about Cronos for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cronos Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cronos Group generated a negative expected return over the last 90 days
Cronos Group may become a speculative penny stock
About 47.0% of the company shares are held by company insiders
Latest headline from insidermonkey.com: Is Cronos Group Inc. the Best Cannabis Stock to Buy According to Billionaires
Evaluating Cronos' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cronos' stock performance include:
  • Analyzing Cronos' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cronos' stock is overvalued or undervalued compared to its peers.
  • Examining Cronos' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cronos' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cronos' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cronos' stock. These opinions can provide insight into Cronos' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cronos' stock performance is not an exact science, and many factors can impact Cronos' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
0.11
Revenue Per Share
0.308
Quarterly Revenue Growth
0.267
Return On Assets
(0.03)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.